Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Roche's novel Aurora kinase inhibitor shows promising preclinical profile

July 21, 2008

Novartis to initiate phase III trial of Antisoma's ASA-404 in NSCLC

July 21, 2008

New anticancer agents described in recent patent literature

July 21, 2008

Tavocept increases survival in NSCLC study

July 18, 2008

Pieris selects PRS-050 as first product in pipeline based on anticalin

July 18, 2008

CGEN-50001 to begin proof-of-concept study in breast cancer in 2009

July 18, 2008

Suspension of phase II trial of doxorubicin Transdrug

July 17, 2008

Erbitux approved in Japan for metastatic colorectal cancer

July 17, 2008

Pro-Pharmaceuticals requests pre-IND meeting with FDA to define regimen for EZ-646

July 16, 2008

Infinity discontinues enrollment in phase II IPI-504 study in prostate cancer

July 16, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...